Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Dermatologic 1

Conditions

Breast Neoplasms 539Neoplasms 482Carcinoma, Non-Small-Cell Lung 395Prostatic Neoplasms 314Colorectal Neoplasms 300Lung Neoplasms 265Neoplasm Metastasis 222Ovarian Neoplasms 199Leukemia, Myeloid, Acute 197Pancreatic Neoplasms 187Multiple Myeloma 174Recurrence 135Squamous Cell Carcinoma of Head and Neck 133Stomach Neoplasms 131Brain Neoplasms 131Melanoma 127Carcinoma, Hepatocellular 126Glioblastoma 121Endometrial Neoplasms 121Triple Negative Breast Neoplasms 113Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 104Head and Neck Neoplasms 100Carcinoma, Renal Cell 98Lymphoma 96Urinary Bladder Neoplasms 93Sarcoma 91Glioma 88Rectal Neoplasms 83Small Cell Lung Carcinoma 82

Interventions

sonelokimab 1risankizumab 1cabozantinib 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Platinum Compounds 1Nivolumab 1Methods 1Ipilimumab 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Arthritis, Psoriatic × 90 days × Clear all
NCT06641089 2026-06-12

IZAR-2

MoonLake Immunotherapeutics AG

Phase 3 Recruiting
600 enrolled

Arthritis, Psoriatic

NCT03816345 2026-06-11

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

National Cancer Institute (NCI)

Phase 1 Recruiting
300 enrolled
Other hematologic neoplasm

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡